Ant Group Releases 2020 CSR Report: Digital Technology Can Help Create a Better Future
Ant Financial Services Group (“Ant Group”) has released its 2020 Corporate Social Responsibility (CSR) report, detailing its efforts to leverage the power of digital technology to build a better future, particularly as communities across the globe continue to grapple with challenges posed by COVID-19.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200520005934/en/
Together with its partners, Ant Group leverages digital technology to provide inclusive services, empower consumers and businesses, and enable a digital life accessible to all. (Photo: Business Wire)
At the heart of Ant Group’s CSR efforts is a commitment to finding innovative yet simple ways to leverage digital technology and create a digital life that is accessible for all. In the current economic climate, the need to bridge the digital gap – that remains a hindrance for many people around the world – and thereby empower people is more pressing than ever.
As the CSR report shows, digital technologies have the power to invigorate social economic development and support stable and long-term economic growth. Inclusive finance programs that leverage digital technologies empower the small and micro-sized economy, an important part of China’s economy.
As of the end of 2019, MYbank, a leading online private commercial bank under Ant Group, had served 20.87 million Small and Micro Enterprises (SMEs) and individually owned businesses, of which 80% had never obtained a business loan from a bank before.
“Digital technology has played a pivotal role in combating COVID-19 and enabling consumers and businesses to resume work and life as soon as possible,” says Eric Jing, Executive Chairman of Ant Group. “Now more than ever, we recognize the power of digital technology to transcend geographical and information gaps and help countries and institutions work together, be it during natural disasters or in daily life. Together, we can leverage technology to build a better society for the future.”
Since the start of the COVID-19 pandemic in January 2020, Alipay has launched a variety of services and measures to mitigate the impact on individuals and SMEs and support their road to recovery. Many of the digital lifestyle service platforms enabled by Alipay have also played an important role in creating jobs and employment opportunities during the pandemic.Initiatives include:
- Launching the “Anti-COVID-19 Express Services,” a dedicated section in the Alipay app, in late January to minimize the impact of COVID-19 on people’s daily lives. The section aggregates services provided by partners supporting this initiative, including: real-time updates on COVID-19; online medical consultations; online grocery delivery services; and enabling donations to charitable organizations via Alipay. As of mid-February, these services had saved users from making at least 90 million trips out of their homes, helping to protect them during the pandemic.
- Enabling multiple regions across China to distribute consumption coupons via Alipay mini program, spurring economic growth as SMEs continue to resume regular business operations. Since March 2020, cities including Nanjing, Hefei, Hangzhou, and Wenzhou, amongst others, have distributed consumption coupons worth over RMB4 billion to citizens via Alipay.
- MYbank also announced a series of measures, including waiving or cutting interest rates, to help small and micro business owners overcome the economic impact of the COVID-19 outbreak, especially those at the epicenter in Hubei Province. Further, merchants using the Alipay platform can also apply for loans offered by the “Contactless Loans” initiative jointly launched by MYbank and 100 partner banks in China.
In 2019, Alipay also reviewed its alignment to the UN Sustainable Development Goals (SDGs), identifying a clear focus on 11 goals. Moving forward, Alipay’s efforts will focus on mapping out a blueprint to continue connecting Alipay’s core capabilities with the UN SDGs, thus contributing to the realization of the global sustainable development agenda.
Meanwhile, Ant Group’s long-standing environmental and philanthropic efforts continue to grow and benefit society. Alipay Ant Forest, the signature tree planting program on Alipay launched in 2016, continues to inspire and attract new users. As of May 2020, Alipay Ant Forest has attracted 550 million users to plant 200 million real trees, reducing carbon emission by 12 million tons. Further, on September 19, 2019, Alipay Ant Forest was awarded the United Nation’s highest environmental honor – the “UN Champions of the Earth” award – for inspiring over half a billion people to take action in their daily lives and adopt greener lifestyles, and helping protect the environment through the power of digital technology. One week later, Alipay Ant Forest won the 2019 UN Global Climate Action Award for using digital technologies to scale up climate action.
Meanwhile, the Alipay Love Online Donation platform, which was launched in 2008 to initially help raise funds for disaster relief efforts in post-earthquake Wenchuan, had raised over RMB 3 billion as of March 2020.
As a responsible corporate citizen and an innovative technology provider that aims to bring inclusive financial services to the world, Ant Group issues a CSR report every year, capturing the key initiatives and milestones the Group has achieved in leveraging technology to build a better society for the future.
Internally, Ant Group encourages every employee to participate in community service projects, resulting in over 60,000 staff volunteer hours in 2020.
For the full report, please click https://www.antfin.com/responsibility.htm
About Ant Group
Ant Financial Services Group (“Ant Group”) is dedicated to using technology to bring the world equal opportunities. Our technologies, including blockchain, artificial intelligence, security, Internet of Things and computing empower us and our ecosystem partners to serve the unbanked and underbanked, bringing more secure, transparent, cost-effective and inclusive financial services to individuals and small and micro-sized individual customer and small businesses worldwide.
Ant Group has formed international partnerships with global strategic partners to serve local users in those markets, and we serve Chinese travelers overseas by connecting Alipay with online and offline merchants. Brands under Ant Group include Alipay, Ant Fortune, MYbank, and WorldFirst. For more information, please visit our website at www.antfin.com or follow us on Twitter @AntFinancial.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
bitFlyer Europe and Quazard Partner to Bring First Ever Trading Competition to Botwars Ultimate Trading1.6.2020 06:00:00 CEST | Press release
Leading cryptocurrency exchange bitFlyer, is partnering with crypto-trading game developer Quazard, to bring the first ever gamified trading competition to the Botwars Ultimate Trading universe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200531005005/en/ bitFlyer and Quazard bring the first gamified trading competition to the Botwars Ultimate Trading universe (Graphic: Business Wire) The competition, which launches today, allows Botwars players to compete in a free to enter crypto-trading simulator to win real Bitcoin. This is the first trading competition to launch on Botwars, and the only live trading competition of its type. In Botwars Ultimate Trading, players need to build an army of trading robots (each representing a trade) and lead them into battle to conquer the cryptocurrency markets. Botwars is a real-time, gamified currency trading experience where you will learn new trading skills, unlock powerful new tradin
Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment, Showing Improvement in Recovery Time1.6.2020 03:00:00 CEST | Press release
Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the virus causing COVID-19. The treatment was also able to show improvement in lung lesions to a normal activity level in animal models. The pre-clinical study was conducted in an animal model in collaboration with one of the Korean National Universities, Chungbuk National University College of Medicine. The trial set out to assess the efficacy of two dosage amounts (low and high) for the antiviral antibody treatment. In comparison to the placebo-controlled group, the research team observed improved recovery in terms of clinical symptom scores such as runny nose, cough and body aches, after the first day of treatment. From the fifth day, significant clinical remission was observed. Reverse transcriptase polymerase chain reaction (RT-PCR) measurement and cell culture-based viral diagnosis were used to a
Idriverplus Joins the “Automate with Velodyne” Ecosystem29.5.2020 20:31:00 CEST | Press release
Velodyne Lidar, Inc. and Idriverplus today announced an expanded partnership and Idriverplus inclusion into the Automated with Velodyne integrator ecosystem, which helps companies grow their businesses while using Velodyne lidar technology. Through the program, Velodyne will further collaborate with Idriverplus to support its continued innovation and promote Idriverplus autonomous vehicles, including street cleaners, passenger cars and logistics vehicles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200529005589/en/ Velodyne Lidar, Inc. and Idriverplus announced an expanded partnership and Idriverplus inclusion into the Automated with Velodyne integrator ecosystem, which helps companies grow their businesses while using Velodyne lidar technology. (Photo: Velodyne Lidar) Recently, Velodyne signed a multi-year sales agreement with Idriverplus to provide Puck™ sensors for the mass production of autonomous vehicles. Idriverplu
Interim Data from the Open Label Phase 2 OPTIC Study of Iclusig ® (ponatinib) for Chronic Phase-CML Presented at the ASCO and EHA Virtual Meetings29.5.2020 14:00:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced that data from the interim analysis of the Phase 2 OPTIC (Optimizing Ponatinib Treatment In CML) trial, which was sponsored by Takeda and co-funded by Incyte, will be presented during an oral session at the upcoming 2020 American Society of Clinical Oncology Virtual Meeting (ASCO20; May 29 – May 31) (Abstract #7502)1; and at the virtual 25th Congress of the European Hematology Association (EHA25; June 11 – 14) (Abstract #S172)2. The OPTIC trial is an ongoing randomized, open-label study prospectively evaluating response-based dosing regimens of Iclusig® (ponatinib) over a range of three starting doses (45 mg, 30 mg, 15 mg) with the aim of optimizing its efficacy and safety in patients with chronic-phase chronic myeloid leukemia (CP-CML), who are resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. With a median follow up of approximately 21 months, data from the interim analysis of the OPTIC trial show that the optimal benefit-r
Takeda to Present Data from the ICLUSIG ® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML29.5.2020 14:00:00 CEST | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that interim analysis data from the Phase 2 OPTIC (Optimizing Ponatinib Treatment In CML) trial will be presented during an oral session at the virtual 56thAmerican Society of Clinical Oncology (ASCO) Annual Meeting and the 25thEuropean Hematology Association (EHA) Annual Meeting. The OPTIC trial is an ongoing, randomized, open-label study prospectively evaluating response-based dosing regimens of ICLUSIG® (ponatinib) over a range of three starting doses (45-, 30-, or 15-mg) with the aim of optimizing its efficacy and safety in patients with chronic-phase chronic myeloid leukemia (CP-CML) who are resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. With a median follow-up of approximately 21 months, data from the interim analysis of OPTIC show that the optimal benefit-risk profile for ICLUSIG in patients with CP-CML is achieved with a daily starting dose of 45-mg and, upon achieving ≤1% BCR-A
Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO ® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks29.5.2020 14:00:00 CEST | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on a Type II Variation regulatory application and recommended the approval of a pre-filled syringe presentation of TAKHZYRO® (lanadelumab). TAKHZYRO is a subcutaneous injectable prescription medication approved in Europe for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. HAE is a rare genetic disorder that results in recurrent attacks of oedema – swelling – in various parts of the body, including the abdomen, face, feet, genitals, hands and throat.1,2,3 “Our goal is to continuously innovate in all areas of HAE management,” said Isabel Kalofonos, Global Product Strategy Lead, HAE, Takeda. “This positive opinion marks another important step forward as we aim to enhance the experience of treatment administration for peo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom